BIO vs OKTA · rev $651.0M vs P/E 84, rev $1.57B
BIO (BIO) versus Okta Inc (OKTA) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
BIO currently screens at market cap $0. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Not investment advice. Open the BIO and OKTA stock pages for the full models.
Not investment advice.